Literature DB >> 2683819

Freeze-fracture studies on the sporoblast and sporozoite development in the early oocyst.

C A Meszoely1, E F Erbe, L M Beaudoin, R L Beaudoin.   

Abstract

Freeze-fracturing has been used to study the formation of the triple layer pellicular complex of budding sporozoites of Plasmodium falciparum in the early oocyst. Sporozoites are formed from sporoblasts within the oocyst. The outer membrane of the sporozoites is derived from the single plasma membrane of the sporoblast while the inner 2 membranes are formed anew at the base of the differentiating sporozoites. A dense collar of intramembranous particles located on the P face of the outer membrane encircles the base of each budding sporozoite. The fact that this collar of intramembranous particles is located in the same region where the inner membranes of the sporozoites first make their appearance strongly suggests that the 2 are related, and that the collar may be related to either membrane synthesis or to membrane organization and assembly.

Entities:  

Mesh:

Year:  1989        PMID: 2683819     DOI: 10.4269/ajtmh.1989.41.499

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

Review 1.  Cytoskeleton of apicomplexan parasites.

Authors:  Naomi S Morrissette; L David Sibley
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

2.  Levels of circumsporozoite protein in the Plasmodium oocyst determine sporozoite morphology.

Authors:  Vandana Thathy; Hisashi Fujioka; Soren Gantt; Ruth Nussenzweig; Victor Nussenzweig; Robert Ménard
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

3.  The ETRAMP family member SEP2 is expressed throughout Plasmodium berghei life cycle and is released during sporozoite gliding motility.

Authors:  Chiara Currà; Marco Di Luca; Leonardo Picci; Carina de Sousa Silva Gomes dos Santos; Inga Siden-Kiamos; Tomasino Pace; Marta Ponzi
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.